Package 65162-028-09

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine
NDC Package

Package Facts

Identity

Package NDC 65162-028-09
Digits Only 6516202809
Product NDC 65162-028
Product ID 65162-028_5fde01e6-09ba-4a92-bd47-aad0d7c518e4
Description

90 CAPSULE in 1 BOTTLE (65162-028-09)

Marketing

Marketing Status
Marketed Since 2023-08-28
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine
Sample Package No

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5fde01e6-09ba-4a92-bd47-aad0d7c518e4", "openfda": {"upc": ["0365162023091", "0365162027099", "0365162025095", "0365162024098", "0365162028096", "0365162026092"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850"], "spl_set_id": ["c11cb3b6-3dff-477b-a249-b4c3118edc5f"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (65162-028-09)", "package_ndc": "65162-028-09", "marketing_start_date": "20230828"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "65162-028_5fde01e6-09ba-4a92-bd47-aad0d7c518e4", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "65162-028", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "70 mg/1"}], "application_number": "ANDA202830", "marketing_category": "ANDA", "marketing_start_date": "20230828", "listing_expiration_date": "20261231"}